Viagra for Women, Shingles Shots, and the Menopause Story Nobody Asks About

Key Takeaways

• ✦A phase 1 trial published August 2026 found topical sildenafil cream was safe and absorbed well in postmenopausal women — it's early-stage research, but the mechanism is sound and the need is real.
• ✦The shingles vaccine Shingrix has now been linked to lower risk of both heart disease and dementia in a large Oxford "natural experiment" — it may be doing more than preventing a painful rash.
• ✦A new NAMS paper makes the case that menopause clinicians need to be screening for intimate partner violence, because the hormonal and psychological shifts of menopause can escalate existing abuse and also be weaponized against women seeking care.
• ✦Female sexual dysfunction affects an estimated 40% of postmenopausal women, and until recently the clinical pipeline has been nearly empty — topical sildenafil is not a cure, but it represents the field finally taking the problem seriously.
• ✦The Shingrix-heart disease finding comes from observational data, not a clinical trial, so causation isn't proven — but the consistency with the earlier dementia finding makes it worth paying attention to, especially since most midlife women should be getting the vaccine anyway.